Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
76 participants
OBSERVATIONAL
2009-01-31
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia
NCT01634542
A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness
NCT01959659
Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment
NCT00692133
Subjective Well Being of Schizophrenic Patients in Greece
NCT00857064
Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment
NCT00809731
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Attended to the mental care units for the first time in 2006
Exclusion Criteria
* Other criteria that according to the medical criteria make difficult the normal development of the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca Pharmaceutical
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Manuel Gomez-Beneyto
Role: STUDY_CHAIR
University of Valencia
Alberto Gonzalez
Role: STUDY_CHAIR
Hospital Universitario Principe de Asturias
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Ferrol, A Coruna, Spain
Research Site
Jerez de la Frontera, Cadiz, Spain
Research Site
Torrejón de Ardoz, Castellon, Spain
Research Site
Avilés, Principality of Asturias, Spain
Research Site
La Plana, Valencia, Spain
Research Site
Bilbao, Vizcaya, Spain
Research Site
Córdoba, , Spain
Research Site
Girona, , Spain
Research Site
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-NES-DUM-2008/4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.